New Leaf Venture Partners’s X4 Pharmaceuticals XFOR Stock Holding History

New Leaf Venture Partners’s Portfolio XFOR Stock Details XFOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-11,167	Closed	-$224K	–	10
2024 Q3	$224K	Hold	11,167	–	–	0.23%	10
2024 Q2	$194K	Hold	11,167	–	–	0.24%	9
2024 Q1	$466K	Hold	11,167	–	–	0.41%	10
2023 Q4	$281K	Hold	11,167	–	–	0.23%	11
2023 Q3	$365K	Hold	11,167	–	–	0.47%	11
2023 Q2	$650K	Hold	11,167	–	–	0.56%	13
2023 Q1	$291K	Hold	11,167	–	–	0.24%	16
2022 Q4	$333K	Hold	11,167	–	–	0.24%	15
2022 Q3	$573K	Hold	11,167	–	–	0.34%	15
2022 Q2	$323K	Hold	11,167	–	–	0.21%	18
2022 Q1	$586K	Hold	11,167	–	–	0.29%	18
2021 Q4	$767K	Hold	11,167	–	–	0.28%	20
2021 Q3	$1.77M	Hold	11,167	–	–	0.51%	18
2021 Q2	$2.18M	Hold	11,167	–	–	0.56%	17
2021 Q1	$2.88M	Hold	11,167	–	–	0.67%	15
2020 Q4	$2.15M	Hold	11,167	–	–	0.5%	13
2020 Q3	$2.27M	Hold	11,167	–	–	0.91%	13
2020 Q2	$3.12M	Hold	11,167	–	–	0.9%	14
2020 Q1	$3.35M	Hold	11,167	–	–	1%	12
2019 Q4	$3.58M	Buy	11,167 +1,667	+18%	+$598K	0.78%	13
2019 Q3	$3.62M	Hold	9,500	–	–	1.1%	13
2019 Q2	$4.28M	Buy	+9,500	New	+$4.83M	1.15%	13

Other funds holding XFOR

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

New Leaf Venture Partners's XFOR Position: Q4 2024 in Review

New Leaf Venture Partners sold out of X4 Pharmaceuticals (XFOR) in Q4 2024, closing a stake of 11,167 shares — an estimated $224K sold.

New Leaf Venture Partners first reported a position in XFOR in Q2 2019 and held it in 22 quarters. The position peaked at $4.28M in Q2 2019. 89 funds tracked by Wall St. Rank hold XFOR as of Q4 2024.

New Leaf Venture Partners reported no remaining X4 Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
New Leaf Venture Partners sold 11,167 X4 Pharmaceuticals shares in Q4 2024, an estimated $224K.
New Leaf Venture Partners first reported a position in X4 Pharmaceuticals in Q2 2019 and held it in 22 quarters.
New Leaf Venture Partners's X4 Pharmaceuticals position peaked at $4.28M in Q2 2019.
89 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q4 2024.

Based on New Leaf Venture Partners's 13F filing for Q4 2024, filed 13 Feb 2025.